Outpatient Chest Tube Management Following Thoracic Resection Improves Patient Length of Stay and Satisfaction Without Compromising Outcomes

Lung Cancer Clinical Trial

Official title:

Outpatient Chest Tube Management Following Thoracic Resection Improves Patient Length of Stay and Satisfaction Without Compromising Outcomes

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

• NCT number: NCT01551082
• Other study ID #: MEM Chest tube study
• Status: Enrolling by invitation
• Phase: N/A
• First received: March 8, 2012
• Last updated: March 9, 2012
• Start date: March 2012
• Est. completion date: January 2013

Study information

• Verified date: March 2012
• Source: Alliance of Cardiothoracic and Vascular Surgeons
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

Discharging patients home with air leak and chest tube to portable drainage device after thoracic resection is cost effective and safe without compromising patients outcome or satisfaction. Despite good outcomes this practice is not done universally by thoracic surgeons.

Description:

Medical chart database to identify patients ,of one thoracic surgeon over the last seven years, who underwent thoracic resection and were discharged home with an air leak and chest tube to portable drainage device was completed. Once all patients were identified, all possible vulnerable patients were discarded. Written consent for participation was obtained by eligible patients and subjects willing to participate were given further explanation of the study. All willing participants completed an Outpatient Chest Tube Quality of Life Questionnaire. Upon completion of the questionnaire participants involvement in the study was complete. Data was collected and correlations between variables statistically analysed to determine significant factors affecting care.

Recruitment information / eligibility

• Status: Enrolling by invitation
• Enrollment: 100
• Est. completion date: January 2013
• Est. primary completion date: January 2013
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 18 Years to 89 Years

Eligibility

Inclusion Criteria:

• all patients 18-89,

• all genders,

• all patients undergoing thoracic resection,

• all patients discharged with chest tube

Exclusion Criteria:

• minors,

• all patients > 90 years old,

• all mentally challenged,

• all non-English speaking patients

Study Design

Observational Model: Cohort, Time Perspective: Retrospective

Related Conditions & MeSH terms

• Lung Cancer
• Pneumothorax
• Subcutaneous Emphysema
• Wounds and Injuries

Locations

Country	Name	City	State
United States	Memorial Hospital	Chattanooga	Tennessee

Sponsors (1)

Lead Sponsor	Collaborator
Alliance of Cardiothoracic and Vascular Surgeons

Country where clinical trial is conducted

United States,